Increased interleukin-10 serum levels in patients with solid tumours

Cancer Letters

Volumn 104, Issue 1, 1996, Pages 1-5

  Fortis, Claudio ^a   Foppoli, Marco ^a   Gianotti, Luca ^a   Galli, Laura ^a   Citterio, Giovanni ^a   Consogno, Giuseppe ^a   Gentilini, Oreste ^a   Braga, Marco ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Immune surveillance; Immunological escape; Interleukin 10; Macrophages; Solid tumour; T lymphocytes

Indexed keywords

INTERLEUKIN 10;

ADULT; ARTICLE; BLOOD LEVEL; COLON CARCINOMA; FIBROMA; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MELANOMA; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; SOLID TUMOR; STOMACH ADENOCARCINOMA; UTERUS TUMOR;

EID: 0029882257     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04213-9     Document Type: Article

References (27)

1. Mosmann, T.R. and Coffman, R.L. (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol., 7, 145-173.
2. + T cells: specificity and function. Immunol. Rev., 101, 39-80.
3. Powrie, F. and Coffman, R.L. (1993) Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol. Today, 14, 270-272.
4. Del Prete, G., De Carli, M., Almerigogna, F., Giudizi, M.G., Biagiotti, R. and Romagnani, S. (1993) Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol., 150, 353-360.
5. Taga, K., Mostowski, H. and Tosato, G. (1993) Human interleukin-10 can directly inhibit T-cell growth. Blood, 11, 2964-2971.
6. Taga, K. and Tosato, G. (1992) IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol., 148, 1143-1148.
7. Howard, M., O'Garra, A., Ishida, H., De Waal Malefyt, R. and De Vries, J. (1992) Biological properties of interleukin 10. J. Clin. Immunol., 12, 239-247.
8. Pisa, P., Halapi, E., Pisa, E.K., Gerdin, E. et al. (1992) Selective expression of interleukin-10, interferon γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc. Natl. Acad. Sci. USA, 89, 7708-7712.
9. Krüger-Krasagakes, S., Krasagakis, K., Garbe, C. et al. (1994) Expression of interleukin-10 in human melanoma. Br. J. Cancer, 70, 1182-1185.
10. Filgueira, L., Zuber, M., Merlo, A. et al. (1993) Cytokine gene transcription in renal cell carcinoma. Br. J. Surg., 80, 1322-1325.
11. Yamamura, M., Modlin, R.L., Ohmen, J.D. and Moy, R.L. (1993)Local expression of antiinflammatory cytokines in cancer. J. Clin. Invest., 91, 1005-1010.
12. Smith, D.R., Kunkel, S.L., Burdick, M.D. et al. (1994) Production of interleukin-10 by human bronchogenic carcinoma. Am. J. Pathol., 145, 18-25.
13. Chen, Q., Daniel, V., Maher, D.W. and Hersey, P. (1994) Production of IL-IO by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int. J. Cancer, 56, 755-760.
14. Gastl, G.A., Abrams, J.S., Nanus, D.M. et al. (1993) Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer, 55, 96-101.
15. Gotlieb, W.H., Abrams, J.S., Watson, J.M., Velu, T.J., Berek, J.S. and Martinez-Maza, O. (1992) Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers. Cytokine, 4, 385-390.
16. Merville, P., Rousset, F., Banchereau, J., Klein, B. and Bataille, R. (1992) Serum interleukin 10 in early stage multiple myeloma. Lancet, 340, 1544-1545.
17. Blay, J.Y., Burdin, N., Rousset, F., et al. (1993) Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood, 82, 2169-2174.
18. Maffezzini, M., Simonato, A. and Fortis, C. (1996) Salvage immunotherapy with subcutaneous IL-2 and α-IFN for stage D3 prostate carcinoma failing second line hormonal treatment. Prostate, in press.
19. De Waal Malefyt, R., Yssel, H. and De Vries, J.E. (1993) Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. J. Immunol., 150, 4754-4765.
20. De Waal Malefyt, R., Haanen, J., Spits, H. et al. (1991) Interleukin 10 (IL-10) and viral IL-IO strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med., 174,915-924.
21. Bejarano, M.T., De Waal Maleftyt, R., Abrams, J.S., Bigler, M., Bacchetta, R., De Vries, J.E. and Roncarolo, M.G. (1992) Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int. Immunol., 4, 1389-1397.
22. De Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C.G. and De Vries, J.E. (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med., 174, 1209-1220.
23. Kambayashi, T., Alexander, H.R., Fong, M. and Strassmann, G. (1995) Potential involvement of IL-10 in suppressing tumor-associated macrophages. J. Immunol., 154, 3383-3390.
24. Willems, F., Marchant, A., Delville, J.P. et al. (1994) Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur. J. Immunol., 24, 1007-1009.
25. Seitz, M., Loetscher, P., Dewald, B., Towbin, H., Gallati, H. and Baggiolini, M. (1995) Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur. J. Immunol., 25, 1129-1132.
26. Nabioullin, R., Sone, S., Mizuno, K. et al. (1994) Interleukin-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages. J. Leukoc. Biol., 55, 437-442.
27. Emilie, D., Touitou, R., Raphael, M. et al. (1992) In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur. J. Immunol., 22, 2937-2942.